Alteration of Substrate Specificity by Common Variants, E158K/E308G and V257M, in Human Hepatic Drug-metabolizing Enzyme, Flavin-containing Monooxygenase 3
![]() |
Lee, Jung-Kyu
(Department of Pharmacology, College of Medicine, Inha University)
Kang, Ju-Hee (Department of Pharmacology, College of Medicine, Inha University) Cha, Young-Nam (Department of Pharmacology, College of Medicine, Inha University) Chung, Woon-Gye (Department of Pharmacology, College of Medicine, Inha University,Medicinal Toxicology Research Center, Inha University) Park, Chang-Shin (Department of Pharmacology, College of Medicine, Inha University,Medicinal Toxicology Research Center, Inha University) |
1 | Cashman JR. Structural and catalytic properties of the mammalian flavin-containing monooxygenase. Chem Res Toxicol 8: 165- 181, 1995 DOI ScienceOn |
2 | Kang JH, Chung WG, Lee KH, Park CS, Kang JS, Shin IC, Roh HK, Dong MS, Baek HM, Cha YN. Phenotypes of flavin-containing monooxygenase activity determined by ranitidine N-oxidation are positively correlated with genotypes of linked FMO3 gene mutations in a Korean population. Pharmacogenetics 10: 67-78, 2000 DOI ScienceOn |
3 | Lomri N, Gu Q, Cashman JR. Molecular cloning of the flavincontaining monooxygenase (form II) cDNA from adult human liver. Proc Natl Acad Sci 89: 685-1689, 1992 |
4 | Ziegler DM. Flavin-containing monooxygenases: catalytic mechanism and substrate specificities. Drug Metab Rev 19: 1-32, 1988 DOI |
5 | Lomri N, Yang ZC, Cashman JR. Regio- and stereoselective oxygenations by adult human liver flavin-containing monooxygenase 3. Comparison with forms 1 and 2. Chem Res Toxicol 6: 800-807, 1993 DOI ScienceOn |
6 | Oscarson M, Hidestrand M, Johansson I, Ingelman-Sundberg M. A combination of mutations in the CYP2D6*17 (CYP2D6Z) allele causes alteration in enzyme function. Mol Pharmacol 52: 1034- 1040, 1997 DOI |
7 | Chung WG, Kang JH, Park CS, Cho MH, Cha YN. Effect of age and smoking on in vivo CYP1A2, flavin-containing monooxygenase, and xanthine oxidase activities in Koreans: determination by caffeine metabolism. Clin Pharmacol Ther 67: 258-266, 2000 DOI ScienceOn |
8 | Dolphin CT, Riley JH, Smith RL, Shephard EA, Phillips IR. Structural organization of the human flavin-containing monooxygenase gene (FMO3), the favored candidate for fish-odor syndrome, determined directly from genomic DNA. Genomics 46:260-267, 1997b DOI ScienceOn |
9 | Chung WG, Roh KH, Kim HM, Cha YN. Involvement of CYP3A1, 2B1, and 2E1 in C-8 hydroxylation and CYP1A2 and flavincontaining monooxygenase in N-demethylation of caffeine: identified by using inducer treated rat liver microsomes that are characterized with testosterone metabolic patterns. Chem Biol Interact 113: 1-14, 1998 DOI ScienceOn |
10 | Nagata T, Williams DE, Ziegler DM. Substrate specificities of rabbit lung and porcine liver flavin-containing monooxygenases: Differences due to substrate specificity. Chem Res Toxicol 3: 372- 376, 1990 DOI ScienceOn |
11 | Treacy EP, Akerman BR, Chow LML, Youil R, Bibeau C, Lin J, Bruce AG, Knight M, Danks DM, Cashman JR, Forrest SM. Mutations of the flavin-containing monooxygenase gene (FMO3) cuase trimethylaminuria, a defect in detoxication. Hum Mol Genet 7: 839-845, 1998 DOI |
12 | Cashman JR. Flavin monooxygenases. In: Ioannides C ed, Enzyme systems that metabolize drugs and other xenobiotics, John Wiley & Sons, London, UK, pp 67-93, 2002a |
13 | Ziegler DM. Flavin-containing monooxygenase: enzyme adapted for multisubstrate specificity. Trends Pharmacol Sci 11: 321-324, 1990 DOI ScienceOn |
14 | Dolphin CT, Cullingford TE, Shephard EA, Smith RL, Phillips IR. Differential developmental and tissue-specific regulation of expression of the genes encoding three members of the flavincontaining monooxygenase family of man, FMO1, FMO3 and FMO4. Eur J Biochem 235: 683-689, 1996 DOI ScienceOn |
15 | Overby LH, Carver GC, Philpot RM. Quantitation and kinetic properties of hepatic microsomal and recombinant flavincontaining monooxygenases 3 and 5 from humans. Chem Biol Interact 106:29-45, 1997 DOI ScienceOn |
16 | Cashman JR. Human flavincontaining monooxygenase (form 3): polymorphisms and variations in chemical metabolism. Pharmacogenomics 3: 325-339, 2002b DOI PUBMED ScienceOn |
17 | Chung WG, Kang JH, Roh HK, Lee KH, Park CS, Cha YN. Assessment of flavin-containing monooxygenase (FMO) activity by determining urinary ratio of theobromine and caffeine in a Korean population after drinking a cup of coffee. Korean J Physiol Pharmacol 3: 207-213, 1999 |
18 | Park CS, Chung WG, Kang JH, Roh HK, Lee KH, Cha YN. Phenotyping of flavin-containing monooxygenase using caffeine metabolism and genotyping of FMO3 gene in a Korean population. Pharmacogenetics 9: 155-164, 1999 |
19 | Treacy EP, Akerman BR, Chow LML, Youil R, Bibeau C, Lin J, Bruce AG, Knight M, Danks DM, Cashman JR, Forrest SM. Mutations of the flavin-containing monooxygenase gene (FMO3) cuase trimethylaminuria, a defect in detoxication. Hum Mol Genet 7: 839-845, 1998 DOI |
20 | Chung WG, Cha YN. Oxidation of caffeine to theobromine and theophylline is catalyzed primarily by flavin-containing monooxygenase in liver microsomes. Biochem Biophys Res Commun 235: 685-688, 1997 DOI ScienceOn |
21 | Oliver CF, Modi S, Sutcliffe MJ, Primrose WU, Lian LY, Robert GC. A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation. Biochemistry 36: 1567-1572, 1997 DOI ScienceOn |
22 | Dolphin CT, Janmohamed A, Smith RL, Shephard EA, Phillips IR. Missense mutation in flavin-containing monooxygenase 3 gene, FMO3, underlies fish-odor syndrome. Nature Genetics 17: 491- 494, 1997a DOI ScienceOn |
![]() |